Oligolysine-PEG Crosslinking for Nuclease-Resistant DNA Nanostructures

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

DNA nanostructures are prone to nuclease-mediated degradation and denaturation under low Mg2+ conditions, limiting their utility in physiological settings.

Innovation Solution

Covalently crosslinking DNA nanostructures with oligolysine-PEG copolymers using glutaraldehyde to enhance stability and resistance to nuclease degradation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If DNA nanostructures are used in physiological settings, then they can serve as therapeutics or diagnostic tools, but they are rapidly degraded by nucleases and denatured under low Mg2+ conditions

Engineering Contradiction:
Improveutility in physiological settingsVSAvoidstructural stability
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent combines DNA nanostructures with a cationic oligolysine-PEG copolymer coating to create a composite material. The copolymer consists of oligolysine segments that bind to DNA and PEG segments that provide steric stabilization. This composite structure protects the DNA from nuclease degradation and maintains stability under physiological conditions including low Mg2+ concentrations and varying pH levels.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent modifies the surface properties of DNA nanostructures by changing the charge density and hydrophilicity through copolymer coating. The cationic oligolysine portion neutralizes the negative charge of DNA phosphates, reducing electrostatic attraction to nucleases, while the PEG portion provides hydrophilic stabilization. This parameter change in surface chemistry enables survival in physiological buffers without requiring high Mg2+ concentrations.

Inventive Principle:
Principle #35Parameter changes

2Stability of the object's composition

If high concentrations of Mg2+ are used to stabilize DNA nanostructures, then structural integrity is maintained, but the structures cannot function in physiological buffers with low Mg2+ concentrations

Engineering Contradiction:
Improvestructural integrityVSAvoidcompatibility with physiological buffers
Core Design Contradiction:
Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The cationic oligolysine-PEG copolymer acts as an intermediary between the negatively charged DNA phosphates and the physiological environment. The oligolysine portion binds to DNA phosphates, effectively replacing Mg2+ as the charge-neutralizing agent, while the PEG portion interfaces with the aqueous physiological buffer. This intermediary layer allows structural integrity to be maintained without requiring high Mg2+ concentrations.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the ionic environment requirement by introducing a permanent cationic coating that provides continuous charge neutralization. Instead of relying on Mg2+ concentration parameters, the copolymer coating creates a stable electrostatic environment that maintains DNA structure across a wide range of physiological conditions including low Mg2+, low salt, and varying pH levels.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If DNA nanostructures are coated with oligolysine-PEG copolymer, then nuclease resistance is improved, but the coating may interfere with cellular uptake and biological function

Engineering Contradiction:
Improvenuclease resistanceVSAvoidcellular uptake efficiency
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent uses block copolymer architecture where different segments perform different functions: the oligolysine blocks provide nuclease resistance through DNA binding, while the PEG blocks provide steric stabilization and biocompatibility. This local differentiation of properties within the coating allows simultaneous achievement of protection and cellular compatibility. The amphiphilic nature creates distinct functional zones on the nanoparticle surface.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The combination of cationic oligolysine and neutral PEG in a block copolymer creates a composite coating with balanced properties. The cationic portion ensures nuclease resistance through strong DNA binding, while the neutral PEG portion prevents non-specific protein adsorption and maintains cellular compatibility. This composite structure resolves the contradiction between protection and biological function.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The crosslinked DNA nanostructures exhibit a 10,000-fold increase in lifespan under strenuous nuclease and low-salt conditions, maintaining structural integrity for over 24 hours in physiological buffers.

Implementation Method 1

covalent crosslinking of the copolymer using glutaraldehyde

Methodology Applied
Scientific EffectCrosslinking reaction: Chemical Bonding

Implementation Method 2

crosslinking reaction using, for example, glutaraldehyde

Methodology Applied
Scientific EffectGlutaraldehyde crosslinking: Chemical Bonding

Implementation Method 3

screen the electrostatic repulsion between anionic phosphate backbones

Methodology Applied
Scientific EffectElectrostatic stabilization: Electrostatics

Implementation Method 4

prone to nuclease-mediated degradation

Methodology Applied
Scientific EffectNuclease degradation resistance: Enzyme

Data Source

PatentUS20250262311A1Nucleic acid nanostructures crosslinked with oligolysine
Publication Date: 2025.08.21 DANA FARBER CANCER INSTITUTE INC
  • US20250262311A1 patent drawing
  • US20250262311A1 patent drawing
  • US20250262311A1 patent drawing

AI summary

The present disclosure provides, in some aspects, nucleic acid nanostructures covalently linked to oligolysine-PEG copolymers.